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Primary mesotheliomas are rare tumours derived from the mesothelial cells of
major serous cavities. They most commonly occur in the pleural cavity, but in
recent years the incidence ofperitoneal mesothelioma has been increasing. The
prognosis for these tumours is generally poor, death normally occurring within
one year ofdiagnosis, but can be improved by earlier diagnosis and aggressive
management 1.
The non-specific presentation, and confusion with other more common intra-
abdominal neoplasms rnake early diagnosis difficult. Appropriate investigations
together with a high index ofsuspicion are therefore important ifearly diagnosis
is to be made. We present a case which illustrates many features typical of this
condition and which highlights important aspects of its management.
CASE HISTORY:
A 58 year old joiner presented with a history of abdominal pain, distension,
weight loss and night sweats. He had a past history of asbestos exposure. On
examination he was pale, with clinical signs of ascites. Haemoglobin was 10 g/
dl, serum alkaline phosphatase 117 U/1 and ESR 90 mm/hr. Ultrasonography
confirmed ascites. Barium enema showed no abnormality in the large bowel.
Computed tomography of the abdomen demonstrated peritoneal thickening
with metastatic deposits in the greater omentum, but diagnostic peritoneal
aspiration was uninformative. Tumour markers CEA and CA19-9 were normal.
Diagnostic laparoscopy revealed bloodstained asciticfluidwithgrossthickening
oftheperitoneum, biopsyofwhichshowedmesothelialproliferation in apapillary
configuration with nuclear atypia, consistent with malignant mesothelioma. It
wasdecidedthatneitherchemotherapynorsurgical interventionbeyondrepeated
aspiration was appropriate. The patient remains well five months following
diagnosis having had several admissions for peritoneal drainage to provide
symptomatic relief.
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DISCUSSION
Primary peritoneal mesothelioma is a raretumour. Itaccounts forapproximately
10% of all malignant mesotheliomas although some sources quote figures as
high as 40% 2. There is an increasing incidence in the United Kingdom 3. Males
are more commonly affected than females, the male/female ratio in the United
Kingdom being 10: 14'5. When the condition arises in childhood ittendstofollow
a similar clinical pattern to that in the adult 6. Asbestos exposure has been cited
as a major factor in the development of the disease7, but a considerable period
up to a mean of 44 years may elapse between exposure and diagnosis 8.
Peritoneal mesothelioma often presents at an advanced stage with non-specific
symptoms such as abdominal pain, weight loss, anorexia and abdominal
distension. Rarely it has presented with small bowel obstruction, an "acute
abdomen" or symptoms suggestive of testicular torsion 9. The most common
finding on examination is ascites, present inmorethan95% ofcases. The patient
may be anaemic or more rarely have a metabolic upset due to ectopic hormone
production1I' 1.
Most mesotheliomas have been diagnosed at autopsy, but increasing numbers
are now diagnosed ante-mortem. A normal CEA level helps to exclude a
diagnosis of intra-abdominal adenocarcinoma. Radiological abnormalities are
non-specific; ultrasonography will reveal ascitic fluid and intra-abdominal
masses, and computed tomography will demonstrate peritoneal thickening.
Peritoneal fluidaspiration provides a cytological diagnosis butcarries both a high
false positive and false negative rate13. Until recently laparotomyofferedthe only
sure method of diagnosis, but laparoscopy has now become invaluable and
provides an opportunity for histological diagnosis and visual assessment of the
extent of the disease process with relatively little patient upset.
WhitwellandRawcliffeofferedthefirsthistological classificationofmesotheliomas
in 1971 14. They described three histological subtypes, epithelial, diphasic, and
fibrous. The majority ofperitoneal mesotheliomas are oftheepithelial form. Until
recently the management ofthis tumour could do little to alter its bad prognosis.
Surgical intervention may provide the diagnosis, but otherwise is limited to
debulking the tumour and relieving bowel obstruction. Many chemotherapeutic
regimes have beentried, the best results being from cisplatinum anddoxorubicin
compounds1
Peritoneal mesothelioma is a highly malignant condition. Its development is
linked with asbestos exposure, which is relevant to the population of Northern
Ireland with its high reliance on the shipbuilding industry in the past. Early
diagnosis requires a high index ofclinical suspicion and should be considered in
patientspresentingwithascitesinwhomserologicalandradiological investigations
have proved uninformative.
We acknowledge the histopathological assistance of Dr V Shah and Dr R W Lyness of the
histopathology department, Belfast City Hospital.
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